Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vistagen Therapeutics (VTGN) Debt Ratio (2020)

Vistagen Therapeutics (VTGN) has disclosed Debt Ratio for 3 consecutive years, with 0.0 as the latest value for Q3 2020.

  • Quarterly Debt Ratio changed N/A to 0.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was 0.0 through Sep 2020, changed N/A year-over-year, with the annual reading at 0.03 for FY2016, N/A changed from the prior year.
  • Debt Ratio hit 0.0 in Q3 2020 for Vistagen Therapeutics, down from 0.02 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.03 in Q1 2016 to a low of 0.0 in Q3 2020.